Head of Operations
RetinAI Medical
Head of Operations
RetinAI Medical
AI-driven ophthalmology imaging data platform
RetinAI Medical · Bern, Switzerland (Hybrid) · Full-time · Posted 2026-07-01
Workplace: hybrid
Department: Operations
Ikerian AG (formerly RetinAI Medical, now part of Essilor Luxottica) is a fast-growing medical device software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management solutions to better understand patients and diseases for disease screening and monitoring. Join our diverse team of entrepreneurs, developers, researchers, and commercial experts who are collectively shaping the future of healthcare and eyecare.
The Head of Operations is the head of Ikerian’s operational maturity and global scaling. Your mission is to install a high-performance 'Operating System’ that synchronizes Research, Development, and Commercial engines into a unified machine, driven by scalable organizational processes and the leadership of cross-functional teams including Project Management, Human Resources,and Quality & Regulatory Affairs. As the primary custodian of our external ecosystem, you will professionalize our vendor management and institutionalize our internal knowledge infrastructure and processes. Following Ikerian’s acquisition by EssilorLuxottica, you will lead the evolution from a high-growth startup to a world-class subsidiary, ensuring our complex dual-business model is anchored by a robust, compliant, and transparent operational framework.
Powered by Workable
AI-driven ophthalmology imaging data platform
RetinAI Discovery is an AI-powered, subscription-based data platform for ophthalmology and optometry that lets eye-care professionals, researchers and sponsors collect, harmonize, analyze and securely share imaging and other medical data (DICOM and proprietary formats). It uses AI to extract insights on disease progression and treatment outcomes, helping clinicians and trial teams make faster, data-driven decisions with capabilities for data collection, processing, visualization and global collaboration. It differentiates itself by focusing specifically on eye care, offering an end-to-end platform that handles diverse data formats and cross-institution collaboration, supported by its US subsidiary and strong investor backing. Its goal is to streamline data-driven clinical decisions and make ophthalmology trials more efficient, expanding within the Ikerian group and its connection to EssilorLuxottica.
Explore more opportunities at RetinAI Medical